Replies to post #23864 on BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

Gold stated,"It was a gamble and I lost. I have no one to blame for that but myself.

And Yet he also posted,"Go find someone else to blame for the stock price. How about MORO??? I bet Smithline wishes he had never heard of Moro or RECAF.

He then posted,"Don't attempt to blame others for personal bad decisions."

[HALF FULL GLASS]

Gold posted," I have found nothing positive on RECAF or a universal marker. That is just a fact."

This seems to contradict his other statements such as:

If Inverness proceeds and is successful in marketing a RECAF product, BioCurex would indeed definitely succeed also.

If Inverness made a positive announcement, investors here would no doubt gamble that RECAF might be successful.

I have stated that RECAF could probably get approved to monitor colon cancer.

Dakota, I have done extensive research into the technology
that RECAF uses and it WORKS. It will be a huge seller and IMO, look for some data to be presented at the July 24th conference in a presentation by the lead developer of the RECAF test at Abbott. Dr. Moro will go down in history as one of the leading developers of cancer detection and treatment.

The personalization aspect of the test is huge. Any developing cancer will cause your RECAF level to dramatically increase. It detects the level of cancer cell division so any change in your normal level is a RED ALERT. Researchers are developing treatments that use the same technology so it does not really matter where the cancer is.

"I have never stated that RECAF could not be used for therapeutics."

"It works like nothing else out there"

"I know the test can detect cancer cells."

"I in fact agree that studies show it does detect if cancer is present in the body."

"The test works and was proven at the ISOBM."

"I think that RECAF may get approval to monitor existing cancer "

"BTW, I have always stated that the RECAF test does indeed work."

"The test works as demonstrated at the ISOBM so IMO, there is no more tweeking necessary."

" This is actually a good idea...if everything goes as Moro states, I do think Moro will get revenue from this test. In fact, it may be his best source of revenue for the product period."